Abstracts by keywords: health care use
In addition to care in the acute phase, the guideline-based therapy scheme includes maintenance therapy after the depressive episode has subsided and prophylaxis for future episodes. Psychotherapy and pharmacotherapy are demonstrably effective treatment methods. Of the large number of people with depression requiring treatment, however, only a minority, estimated at less than 10 percent, receive adequate treatment (DGPPN et al. 2015). There are many possible reasons for this: a lack of hope and reduced drive on the part of those affected to get help, delayed diagnosis, deviation from the therapeutic guidelines in everyday family doctor work, and an insufficient range of psychotherapy places and the associated long waiting times. In addition, there are often irrational reservations on the part of those affected or their relatives about antidepressants, shame and stigmatization of the disease in the social environment, etc. This results in an urgent need for action - also for the private insurance industry -, the supply deficits due to inadequate medical supply structures and as a result of the disease and society-related high To lower the access threshold of utilization for the individual patient.